ASCO announces new president-elect
Click Here to Manage Email Alerts
Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO, has been named president-elect of ASCO and will lead the 2026 to 2027 term.
Mittendorf, the Robert and Karen Hale endowed chair in the department of surgical oncology and vice chair for research in the department of surgery at Brigham and Women’s Hospital, will assume office as president-elect during the annual meeting in Chicago on June 2, 2025, according to a press release.
As a “long-time ASCO member and volunteer,” Mittendorf served on the ASCO Board of Directors from 2019 to 2023, as ASCO treasurer from 2022 to 2023, a past chair of the Conquer Cancer Grants and Awards Selection Committee, and past member of the Annual Meeting Scientific Program Committee and Best of ASCO Planning Committee.
Mittendorf is also the director of the breast immuno-oncology program, co-leader of Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, and co-leader of the breast program for the Dana-Farber/Harvard Cancer Center, according to the release.
“I’m honored and humbled by the opportunity to serve as president of ASCO and help guide this multifaceted organization as we work to conquer cancer through research, education and promotion of the highest-quality, equitable patient care,” Mittendorf said in the release. “I look forward to supporting this global membership and our collective efforts to improve outcomes for our patients.”
Read more about
Click Here to Manage Email Alerts